Dr. Ankur Bahl is a highly skilled Medical Oncologist with over 15 years of experience in the field of cancer care. Based in Delhi, India, Dr. Bahl specializes in a wide range of oncological treatments, including immunotherapy, targeted therapies, chemotherapy, hormonal therapy, and palliative care. He is an expert in head and neck cancers, acute myeloid leukaemia, and human papillomavirus trends in the Indian population. Dr. Bahl has authored numerous publications and is a pioneer in oncology education through international and national platforms. With training from prestigious institutions like AIIMS New Delhi and University of Oxford, Dr. Bahl is known for his expertise in evidence-based oncology and his commitment to advancing cancer care through research and education.

Experience Overview

• Expertise in immunotherapy, targeted therapies, chemotherapy, hormonal therapy, and palliative care

• Specializes in head and neck cancers, acute myeloid leukaemia, and human papillomavirus trends in the Indian population

• Work Experience:

  • Currently working at FMRI, Gurugram as Medical Oncologist

  • Formerly Director of Medical Oncology and Haematology Oncology at Max Hospital, Saket

  • Previously associated with Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College

  • Founder and leader of innovative oncology educational platforms and networks (both national and international)

  • Lead author of major Indian real-world data studies in targeted therapies (Cetuximab in head and neck cancer) and acute myeloid leukaemia treatment

  • Active advisor to various biopharmaceutical research & development organizations

  • Mentor to international and national oncology fellows and students

  • Led NGOs for “No Tobacco” workshops in Delhi schools

Professional Memberships

• Member of the Indian Society of Medical and Pediatric Oncology (ISMPO)

• Member of the European Society for Medical Oncology (ESMO)

• Member of the American Society of Clinical Oncology (ASCO)

• Member of the Indian Medical Association (IMA)

• Advisory Role in various Biopharmaceutical Research & Development organizations

Awards & Accolades:

• Lead author of the largest real-world Indian data on Cetuximab in Head & Neck cancer

• Lead founder of innovative oncology educational platforms and networks

• Numerous publications in leading international and national journals

• Advisor to various NGOs conducting “No Tobacco” workshops in Delhi Schools

• Guide to national and international Medical Oncology fellows

Specialty Interests:

• Immunotherapy and Targeted Therapy in cancer treatment

• Expertise in Chemotherapy, Hormonal Therapy, and Supportive Care

• Focused on Head & Neck Cancer, Acute Myeloid Leukaemia, and Human Papillomavirus (HPV) trends in India

• Strong interest in educational initiatives and advocacy for cancer awareness

Languages Spoken

• English

• Hindi

• Punjabi